Over-The-Counter (OTC) Medication Sales Flag in 2013

Published in CSP Daily News

Pain Relievers        
Remedy type C-store sales ($ millions) PCYA Unit sales (millions) PCYA
Internal analgesic tablets $327.1 -1.8% 159.9 -5.8%
Internal analgesic liquids $5.8 29.5% 0.9 28.7%
Feminine pain relievers $5.5 -0.9% 1.8 8.0%
Total internal analgesics (including segments not shown) $338.5 -1.4% 162.5 -5.5%
Cold/Allergy/Sinus        
Tablets/packets $117.4 -4.7% 42.8 -3.6%
Liquids $29.4 4.3% 3.7 -1.3%
Cough Remedies        
Cough drops $98.4 3.5% 67.6 1.0%
Cough syrups $6.2 -6.9% 1.0 -7.0%
Gastrointestinal        
Antacid tablets $77.0 -1.7% 51.2 -5.0%
Gastrointestinal liquids $20.3 -6.9% 4.7 -11.4%
Stomach remedy tablets $13.4 14.8% 5.5 12.0%
Antacid/analgesic combo $9.7 -7.9% 5.0 -6.7%
Diarrhea tablets $6.5 -24.1% 3.2 -8.8%

Source: IRI

Click here for the most recent data in CSP's Category Management Handbook.

IRI

Click here for more yearend healthcare/general merchandise sales data

C-store sales of over-the-counter (OTC) medication flagged in 2013, with even the largest segment—analgesics—seeing declines. Dollar sales of analgesics fell by 1.4% and unit sales fell 5.5%, according to IRI. Cold, allergy and sinus tablets saw smaller declines than in 2012 but still gave up nearly 5% ofdollar sales and nearly 4% in units. Gastrointestinal-remedy dollars were down by 2% and units fell more than 4%.

Related Topics: 
HBC, over the counter